ReviewEBioMedicine2022

The difficulty in translating the preclinical success of combined TGFβ and immune checkpoint inhibition to clinical trial.

Anastasia E Metropulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.